References
- Arber, D.A., et al., 2016. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127 (20), 2391–2405.
- Beck, D., et al., 2018. A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. Leukemia, 32 (2), 263–272.
- Bennett, J.M., et al., 1985. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Annals of internal medicine, 103 (4), 620–625.
- Cabili, M.N., et al., 2011. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes & development, 25 (18), 1915–1927.
- Chapuis, N., et al., 2010. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica, 95 (3), 415–423.
- De Clara, E., et al., 2017. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients. Haematologica, 102 (10), 1718–1726.
- Derrien, T., et al., 2012. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research, 22 (9), 1775–1789.
- Djebali, S., et al., 2012. Landscape of transcription in human cells. Nature, 489 (7414), 101–108.
- Döhner, H., et al., 2017. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood, 129 (4), 424–447.
- Döhner, H., Weisdorf, D.J., and Bloomfield, C.D., 2015. Acute myeloid leukemia. The New England journal of medicine, 373 (12), 1136–1152.
- Engreitz, J.M., et al., 2016. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature, 539 (7629), 452–455.
- Feng, J., et al., 2015. A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer. International journal of clinical and experimental pathology, 8 (10), 12268–12275.
- Fürstenberger, G., and Senn, H.J., 2002. Insulin-like growth factors and cancer. The lancet oncology, 3 (5), 298–302.
- Garg, M., et al., 2015. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood, 126 (22), 2491–2501.
- Garzon, R., et al., 2014. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proceedings of the national academy of sciences of the United States of America, 111 (52), 18679–18684.
- Grimwade, D., et al., 2010. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116 (3), 354–365.
- Guo, A., et al., 2022. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway. Histology and histopathology, 37 (6), 543–554.
- Hola, M.A.M., et al., 2021. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia. International journal of laboratory hematology, 43 (4), 732–742.
- Huarte, M., 2015. The emerging role of lncRNAs in cancer. Nature medicine, 21 (11), 1253–1261.
- Iyer, M.K., et al., 2015. The landscape of long noncoding RNAs in the human transcriptome. Nature genetics, 47 (3), 199–208.
- Jiang, Y., Chen, J., and Chen, G., 2019. Long noncoding RNA IRAIN acts as tumor suppressor via miR-125b in multiple myeloma. Oncology letters, 18 (6), 6787–6794.
- Kanduri, C., 2016. Long noncoding RNAs: Lessons from genomic imprinting. Biochimica et biophysica acta, 1859 (1), 102–111.
- Kang, L., et al., 2015. Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers. European journal of cancer, 51:260–270.
- Kantarjian, H., et al., 2021. Acute myeloid leukemia: current progress and future directions. Blood Cancer journal, 11 (2), 41.
- Kayser, S., and Levis, M.J., 2022. Updates on targeted therapies for acute myeloid leukaemia. British journal of haematology, 196 (2), 316–328.
- Kirtonia, A., et al., 2020. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. Journal of molecular medicine (Berlin, Germany), 98 (8), 1069–1091.
- Kirtonia, A., et al., 2022. Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia. Journal of cellular physiology, 237 (1), 450–465.
- Lei, L., et al., 2018. Genome-wide characterization of lncRNAs in acute myeloid leukemia. Briefings in bioinformatics, 19 (4), 627–635.
- Ley, T.J., et al., 2013. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England journal of medicine, 368 (22), 2059–2074.
- Li, Y., et al., 2020. Long non-coding RNA IRAIN inhibits VEGFA expression via enhancing its DNA methylation leading to tumor suppression in renal carcinoma. Frontiers in oncology, 10, 1082.
- Lian, Y., et al., 2016. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer. Tumour biology : the journal of the international society for oncodevelopmental biology and medicine, 37 (11), 14929–14937.
- Madan, V., et al., 2016. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia, 30 (8), 1672–1681.
- Marcucci, G., et al., 2014. Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score. Journal of clinical oncology : official journal of the American society of clinical oncology, 32 (6), 548–556.
- Mer, A.S., et al., 2018. Expression levels of long non-coding RNAs are prognostic for AML outcome. Journal of hematology & oncology, 11 (1), 52.
- Metzeler, K.H., et al., 2016. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood, 128 (5), 686–698.
- Morlando, M., Ballarino, M., and Fatica, A., 2015. Long non-coding RNAs: new players in hematopoiesis and leukemia. Frontiers in medicine, 2, 23.
- Newell, L.F., and Cook, R.J., 2021. Advances in acute myeloid leukemia. BMJ (clinical research ed.), 375, n2026.
- Ng, M., Heckl, D., and Klusmann, J.H., 2019. The regulatory roles of long noncoding RNAs in acute myeloid leukemia. Frontiers in oncology, 9, 570.
- Papaioannou, D., et al., 2017. Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. Haematologica, 102 (8), 1391–1400.
- Pashaiefar, H., et al., 2018. Low expression of long noncoding RNA IRAIN is associated with poor prognosis in non-M3 acute myeloid leukemia patients. Genetic testing and molecular biomarkers, 22 (5), 288–294.
- Quinn, J.J., and Chang, H.Y., 2016. Unique features of long non-coding RNA biogenesis and function. Nature reviews genetics, 17 (1), 47–62.
- Reinmuth, N., et al., 2002. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clinical cancer research : an official journal of the American association for cancer research, 8 (10), 3259–3269.
- Sanz, M.A., et al., 2009. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 113 (9), 1875–1891.
- Seccareccia, E., and Brodt, P., 2012. The role of the insulin-like growth factor-I receptor in malignancy: an update. Growth hormone & IGF research : official journal of the growth hormone research society and the international IGF research society, 22 (6), 193–199.
- Short, N.J., Rytting, M.E., and Cortes, J.E., 2018. Acute myeloid leukaemia. Lancet (london, England), 392 (10147), 593–606.
- Sun, J., et al., 2014. A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies. Nucleic acids research, 42 (15), 9588–9601.
- Tsai, C.H., et al., 2019. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. EBioMedicine, 40, 240–250.
- Tyner, J.W., et al., 2018. Functional genomic landscape of acute myeloid leukaemia. Nature, 562 (7728), 526–531.
- Wang, J.Y., et al., 2020. Aberrant allelic-switch of antisense lncRNA IRAIN may be an early diagnostic marker in laryngeal cancer. Oncology letters, 20 (4), 65.
- Wang, Y., 2019. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk. Cancer biomarkers : section A of disease markers, 26 (1), 93–108.
- Wei, S., and Wang, K., 2015. Long noncoding RNAs: pivotal regulators in acute myeloid leukemia. Experimental Hematology & oncology, 5 (1), 1–7.